Rosiglitazone
Rosiglitazone is indicated
- As monotherapy for glycemic control.
- For use in combination with a sulfonylurea, metformin, or insulin when diet, exercise, and a single agent do not result in adequate glycemic control.
- Also for use in combination with a sulfonylurea plus metformin when diet, exercise, and both agents do not result in adequate glycemic control.
There are no products to list in this category.